We recently identi®ed inositol hexakisphosphate kinase 2 (IP6K2) as a positive regulator of apoptosis. Overexpression of IP6K2 enhances apoptosis induced by interferon-b (IFN-b) and cytotoxic agents in NIH-OVCAR-3 ovarian carcinoma cells. In this study, we contrast and compare IFN-b and radiation-induced death, and show that IP6K2 expression sensitizes tumor cells. Unirradiated NIH-OVCAR-3 cells transfected with IP6K2 formed fewer colonies compared to unirradiated vector-expressing cells. IP6K2 overexpression caused increased radiosensitivity, evidenced by decreased colony forming units (CFU). Both IFN-b and radiation induced caspase 8. IFN-b, but not g-irradiation, induced TRAIL in NIH-OVCAR-3 cells. Gamma irradiation, but not IFN-b, induced DR4 mRNA. Apoptotic eects of IFN-b or g-irradiation were blocked by expression of a dominant negative mutant death receptor 5 (DR5D) or by Bcl-2. Caspase-8 mRNA induction was more pronounced in IP6K2-expressing cells compared to vector-expressing cells. These data suggest that overexpression of IP6K2 enhances sensitivity of some ovarian carcinomas to radiation and IFN-b. IP6K2 may function to enhance the expression and/or function of caspase 8 and DR4 following cell injury. Both IFN-b and girradiation induce apoptosis through the extrinsic, receptor-mediated pathway, IFN-b through TRAIL, radiation through DR4, and both through caspase 8. The function of both death inducers is positively regulated by IP6K2.
Introduction
We have previously reported that inositol hexakisphosphate kinase 2 (IP6K2) mediates growth suppressive and apoptotic eects of IFN-b in ovarian carcinoma cells (Morrison et al., 2001) . IP6K2 is a cytoplasmic kinase that catalyses the synthesis of diphosphoinositol pentakisphosphate (InsP 5 PP, contains seven phosphates) using inositol hexaphosphate (IP 6 , contains six phosphates) as a substrate in the presence of ATP (Saiardi et al., 1999) . IP6K2 maps to chromosome 3p21, a region highly susceptible to aberrant chromosomal rearrangements and deletions in human cancers (Bronner et al., 1994; Kok et al., 1987) including ovarian carcinomas (Decristofaro et al., 2001; Rimessi et al., 1994) . Overexpression of IP6K2 causes prolongation of the cell cycle, without arrest in a speci®c phase (Morrison et al., 2001) . Additionally, we found that inhibition of IP6K2 expression and enzymatic activity by use of antisense mRNA or a dominant negative mutant (SUB) resulted in cellular resistance to the antiproliferative eects of IFN-b and cytotoxic agents such as cis-platinum and etoposide. Hence, IP6K2 has many features of a tumor suppressor. Our studies utilized NIH-OVCAR-3 ovarian carcinoma cells, which lack functional p53 (Yaginuma and Westphal, 1992) . This is consistent with earlier observations that normal p53 gene expression is not necessary for induction of death by type I IFNs (IFN-a and IFN-b) (Sangfelt et al., 1997) .
Because IP6K2 overexpression sensitized several dierent cells to the apoptotic eects of cytotoxic agents, we hypothesized that this kinase may also play a role in g-irradiation-induced apoptosis. Therefore, we designed the present experiments to determine if IP6K2 could radiosensitize ovarian tumor cells, and to further probe the mechanism by which IP6K2 regulates apoptosis in cells carrying mutant p53. Ionizing radiation results in activation of multiple genes, DNA strand breaks, and apoptosis in many dierent cell types. Radiationinduced apoptosis has been characterized as p53-dependent, as in thymocytes (Clarke et al., 1993) or p53-independent as in gliomas (Yount et al., 2001) and ®broblasts (Lackinger et al., 2001) .
It is likely that g-irradiation induces apoptosis by activation of both the mitochondrial (intrinsic) pathway and the TNF receptor superfamily (extrinsic) pathway. Irradiation of mitochondria has been shown to initiate apoptosis in a cell free system (Taneja et al., 2001) . Induction of TNF-related apoptosis-inducing ligand, TRAIL/Apo2L has been observed following girradiation of leukemic cells (Gong and Almasan, 2000) . Upregulation of TRAIL receptors DR4 (Guan et al., 2001 ) and DR5 (Burns et al., 2001) and TRADD (Yount et al., 2001 ) following g-irradiation has also been described. To assess the mode of death in ovarian carcinoma cells, we examined whether ionizing radiation would aect expression of any of these death associated gene products and whether overexpression of IP6K2 would aect their activity.
Results

Effect of g-irradiation and IFN-b on expression of IP6K2
To study the eect of g-irradiation and IFN-b on IP6K2 expression, we examined whether its mRNA levels were inducible. IP6K2 mRNA was not induced in NIH-OVCAR-3 cells following either treatment with IFN-b (Morrison et al., 2001) or g-irradiation (data not shown). To determine whether g-irradiation or IFN-b resulted in elevated IP6K2 protein levels, immunoblot (Western blot) analysis was performed using whole cell lysates. Densitometric quantitation of Western blots revealed that elevation of IP6K2 protein levels occurred at 8 h and 16 h after g-irradiation (Figure 1a ). Maximal increase occurred at 8 h (* threefold) at low, therapeutically relevant doses of g-irradiation (1 ± 2 Gy), and declined afterwards. Similarly, IP6K2 protein levels were induced at 8 through 48 h after IFN-b treatment (200 U/ ml) (Figure 1b ). Maximal elevation occurred at 8 h (fourfold induction) and declined thereafter. Hence, two diverse apoptotic stimuli resulted in elevation of IP6K2 protein levels in a time dependent manner. Both g-irradiation and IFN-b induced IP6K2 protein via a post-translational mechanism.
Effect of IP6K2 on clonogenic survival following g-irradiation Clonogenic assays were performed using NIH-OVCAR-3 cells that expressed full length IP6K2 or dierent regions of the IP6K2 protein. To determine which domain of IP6K2 is responsible for cytotoxicity, the IP6K2 protein was expressed as three individual regions, A, B and C (Figure 2a ). The B region contains the putative IPBD, which may be required for inositol phosphate (substrate) binding (Togashi et al., 1997) . Expression of various myc-tagged IP6K2 constructs was veri®ed in NIH-OVCAR-3 cells by Western blotting (Figure 2b ). These included full length IP6K2 (FL), as well as the dominant negative mutant (SUB) that contains point mutations in the IPBD. Overexpression of the SUB mutant inhibits endogenous IP6K enzyme activity (Morrison et al., 2001) .
Unirradiated cells expressing full length IP6K2 formed fewer and smaller colonies compared to unirradiated vector expressing cells (Figure 3a) . Full Figure 1 Eect of g-irradiation and IFN-b on IP6K2 protein levels. (a) NIH-OVCAR-3 cells growing at 75% con¯uence were trypsinized, suspended in 1 ml PBS, and subject to 0, 1 (white bars) or 2 Gy (gray bars) irradiation and replated in complete medium. At 8 and 16 h after plating, cells were harvested, lysed and subject to Western blot analysis using monoclonal anti-IP6K2 antibodies. To control for loading, blots were probed with anti-actin antibodies; bands were digitized and quanti®ed. IP6K2 signal intensity was normalized to actin, then expressed as fold induction, with unirradiated cells representing a protein level of 1. Numbers to left of blot indicate MW markers length IP6K2 overexpression caused increased sensitivity to g-irradiation, resulting in decreased colony forming units (CFU) (Figure 3b ). Compared to unirradiated cells, in vector-expressing cells (white bars), the percentage of CFU formed following 2 and 4 Gy were reduced by 34 and 84%, respectively. In comparison, in IP6K2-expressing cells (black bars), the percentage of CFU formed following 2 and 4 Gy were reduced by 80 and 96%, respectively. Thus, IP6K2 expressed caused a 3.3-fold and 4.4-fold reduction in CFU formation at 2 and 4 Gy, respectively. A linearquadratic model was used to ®t the dose survival curves. The linear parameter a, and the quadratic parameter b for vector expressing (pCXN2) and IP6K2 expressing cells, are listed in Table 1 . To assess the eect of IP6K2 expression on radiosensitivity, Dose Modi®cation Factor (DMF) was calculated by determining D 50 , the radiation dose associated with 50% CFU for each cell line. Hence, DMF is the ratio of pCXN2 D 50 /IP6K2 D 50 , and IP6K2 overexpression translated into a DMF of 1.81.
Expression of IP6K2 region B alone (vertical stripes) conferred a twofold enhancement of radiosensitivity. In contrast, expression of IP6K2 region A or C alone had no eect on sensitivity to g-irradiation. NIH-OVCAR-3 cells expressing the dominant negative mutant SUB (gray bars) displayed radioresistance, re¯ected as 20 and 56% increases in CFU at both dose levels. Cells that overexpressed Bcl-2 (stippled bars) were most radioresistant of all NIH-OVCAR-3 transfectants; compared to vector-expressing cells, CFU were increased 1.4-fold and threefold after 2 and 4 Gy, respectively. DR5D was also eective at blocking radiation-induced death; CFU were increased 1.3-fold and 2.1-fold after 2 and 4 Gy, respectively. We also studied the eects of IP6K2 expression in Caov-3 and Hey ovarian carcinoma cells, which are both relatively resistant to many cytotoxic agents compared to NIH-OVCAR-3 cells. Caov-3 cells exhibited a phenotype very similar to NIH-OVCAR-3 cells, whereas IP6K2 overexpression did not radiosensitize Hey cells (data not shown).
IP6K2 enhances IFN-b-induced growth suppression
We have previously demonstrated that IFN-b caused growth inhibition in NIH-OVCAR-3 cells in vitro (Morrison et al., 2001) . To study the eect of IP6K2 on IFN-b-induced growth suppression, we treated NIH-OVCAR-3 cells expressing vector alone, full length IP6K2, Bcl-2 or DR5D ( Figure 4a ). Cells were grown in the presence of dierent doses of IFN-b. After 1 week, cell growth was measured using a colorimetric assay based on binding of the chromophore sulforhodamine B (Skehan et al., 1990) . The amount of dye retained directly correlates with cell number. IP6K2 expression caused enhanced growth suppression in response to IFN-b. Complete cytostasis occurred at *200 U/ml for IP6K2 express-ing cells compared to *500 U/ml for pCXN2 expressing cells. Cell death was evident at 250 ± 500 U/ml in IP6K2 transfected cells. Bcl-2 eectively blocks growth suppressive eects of IFN-b, reducing the per cent inhibition from 95 (vector expressing cells) to 50% (Bcl-2 expressing cells) at the highest dose tested. DR5D overexpression resulted in near-complete protection against IFN-b. These cells were inhibited only 15% in their growth at the highest dose of IFN-b. Thus, IFN-b mediates growth suppression and apoptosis through pathways that can be suppressed by Bcl-2 and blockade of TRAIL receptors.
To assess the eect of combination treatment we ®rst irradiated NIH-OVCAR-3 cells and then grew Figure 3 Clonogenic assay: SUB mutant, Bcl-2, and DR5D are radioprotective. (a) NIH-OVCAR-3 cells stably expressing pCXN2 vector or IP6K2 received 0, 2 or 4 Gy irradiation and were plated at a density of 5000 cells per 10 cm dish and grown for 30 days. Colonies were ®xed with TCA and stained with sulforhodamine B. Representative plates from each treatment group are shown. (b) Colonies were identi®ed and counted using the Kodak 1DS system. Average colony size was smaller in IP6K2 expressing cells compared to vector transfected cells at equivalent dose levels (not shown). CFU were determined for the indicated NIH-OVCAR-3 cells stably expressing various IP6K2 mutants and indicated proteins. Compared to pCXN2 vector-expressing cells, IP6K2 and B-region expressing cells displayed greatly reduced CFU. In contrast, SUB, Bcl-2, and DR5D expression caused increased CFU, whereas A-region, C-region CFU were no dierent from vector control Numbers in parentheses are 95% con®dence intervals them in the presence of IFN-b as above. IFN-b as a single agent generated a dose response curve similar to Figure 4a . As expected, g-irradiation resulted in increasing growth inhibition as the dose was increased from 0.2 ± 4 Gy ( Figure 4b ). The degree of growth inhibition in the combination group was only marginally greater than that seen following IFN-b as a single agent. Median eect analysis (of which, isobol analysis is a subset) was used to determine the mode of interaction between these two forms of treatment (Chou and Talalay, 1984 ) (Inset, Figure  4b ). The x-axis represents fraction aected and the yaxis represents combination index (C.I.). C.I.41 corresponds to antagonism, C.I.51 corresponds to synergism, and C.I.=1 corresponds to additivity. At all three doses tested, the C.I. indicated an additive mode of interaction between radiation and IFN-binduced growth inhibition, rather than a synergistic mode of interaction. This analysis suggested that IFN-b and g-irradiation may utilize a common pathway for growth suppression and induction of apoptosis.
Effect of IFN-b and IP6K2 on radiation-induced gene expression
To determine whether IFN-b was inducing deathassociated gene mRNAs, ribonuclease protection assays (RPAs) were performed. In untreated cells, caspase 8 and TRAIL mRNAs were barely detectable; IFN-b induced their expression in a dose-dependent manner after 8 h (Figure 5a ). Caspase 8 and TRAIL expression could be completely blocked with actinomycin D, indicating a transcriptional control of their expression. Therefore, cell death induced by IFN-b is associated with caspase 8 and TRAIL expression and death can be abrogated by a dominant negative mutant TRAIL receptor (DR5D).
Since upregulation of death-associated genes by girradiation has been described in several dierent cell lines (Burns et al., 2001; Gong and Almasan, 2000; Guan et al., 2001; Yount et al., 2001) we used RPAs to assess caspase and death receptor expression in ovarian carcinoma cells. In untransfected (not shown) or vector-transfected NIH-OVCAR-3 cells (Figure 5b , lanes 5 ± 7) we observed induction of caspase 8 and DR4 following 2 Gy. Quantitation of these band densities indicated a 2 ± 4-fold induction of caspase 8 and DR4, with the greatest increase at the 4 h time point (Figure 5c , white bars). Importantly, expression of both of these genes was markedly enhanced in IP6K2-overexpressing cells (Figure 5b, lanes 8 ± 14) . Induction was detectable at lower radiation doses (1 Gy) and at earlier time points (Figure 5c , gray bars). Peak induction was sevenfold and ninefold for caspase 8 and DR4, respectively. Death receptor and caspase mRNA induction was blocked by pretreatment with actinomycin D (not shown). A dierent pattern of gene expression was observed in the radioresistant Hey cells (Figure 5b , lanes 15 ± 21). They expressed higher levels of fas, relative to NIH-OVCAR-3 cells, but there was no induction of caspase 8 or DR4 mRNA following irradiation.
Gamma-irradiation, IFN-b, and IP6K2 expression enhance caspase 8 activity
To determine whether the increases in mRNA translated into increased enzymatic activity, cell lysates were analysed for caspase 8 activity following various treatments. After 2 Gy, vector-transfected cells displayed a time-dependent increase in caspase 8 activity, peaking at 24 h and declining thereafter (Figure 6a , white bars). Cells overexpressing IP6K2 had enhanced caspase 8 activity compared to vector controls ( Figure  6a , gray bars), peaking at 48 h. Maximal fold induction of caspase 8 activity was 2.6 and 25.3 in vector-and IP6K2-transfected cells, respectively. Greater enzymatic activity in IP6K2-transfected cells is consistent with the increase in caspase 8 mRNA observed in RPAs (Figure 5b 
Discussion
In ovarian carcinoma cell lines, IFN-b and g-irradiation induce apoptosis using similar but not identical pathways. In sensitive cells, IFN-b upregulates TRAIL, and to a lesser extent, caspase 8 (Figure 5a ). IFN-binduced apoptosis has been associated with TRAIL induction in several dierent tumor cell lines (ChawlaSarkar et al., 2001; Zhang et al., 1999) . g-irradiation clearly upregulates caspase 8 and DR4 mRNA ( Figure  5b ) as well as caspase 8 activity (Figure 6a ). This is consistent with our previous study showing induction of apoptosis following ionizing radiation (Gong and Almasan, 2000) . Transcriptional induction of DR4 following radiation has also been reported in lung carcinoma cell lines (Guan et al., 2001) . Our studies are consistent with others, who have described caspase 8 activation following radiation of Jurkat cells (Belka et al., 2000) . In three dierent ovarian carcinoma cell lines, we observed no induction of TRAIL following radiation treatment. This is in contrast to hematologic cells in which both TRAIL and Fas upregulation has been described (Gong and Almasan, 2000) . Combination therapy utilizing TRAIL and cytotoxic agents (cisplatin, doxorubicin, or paclitaxel) has been proposed, in an eort to overcome the chemoresistance that usually develops following treatment of women with ovarian carcinoma (Cuello et al., 2001) . The p53 status of ovarian carcinoma cells did not correlate with sensitivity to death inducers. In fact, cell lines with mutant p53 (NIH-OVCAR-3, Caov-3) were more sensitive to IFN-b and g-irradiation than cells containing wild-type p53 (Hey).
We found that DR5D protects against apoptosis initiated by both IFN-b and g-irradiation, con®rming that TRAIL : DR-mediated signaling occurs following treatment with both death inducers. Thus, downstream eects of TRAIL and one of its receptors can be blocked by DR5D. Combination treatment with both modalities resulted in additive, rather than synergistic antiproliferative eects (Figure 4b ). Such additivity is consistent with upregulation of the ligand TRAIL and its receptor DR4, components of the same apoptotic pathway. DR4 and DR5, both agonistic receptors for TRAIL, form homomeric and heteromeric complexes upon ligand binding (Kischkel et al., 2000) . Recent reports indicate that ligation of DR4 (Sprick et al., 2000) and DR5 (Bodmer et al., 2000) lead to caspase 8 activation, using a signaling paradigm that is similar, but not identical, to those induced by TNF-a and FasL. Caspase 8 is activated as part of the deathinducing signaling complex (DISC). We show that caspase 8 activity was induced more strongly by radiation compared to IFN-b (Figure 6a,b ). Yet caspase 8 activity following combination treatment , and Hey cells, received 0, 2, or 4 Gy prior to harvesting total RNA. Transfected plasmids, dose of radiation, and times of harvest are indicated at the top of gel. Equal amounts of RNA (10 mg) were subject to ribonuclease protection assay after hybridization to a set of commercially available death associated gene probes labeled with 32 P. Protected RNAs were resolved on polyacrylamide gels, subject to autoradiography and digitized by phosphorimager. The positions of death-associated genes and controls (ribosomal protein L32, and glyceraldehyde-3-phosphate dehydrogenase, GAPDH) are indicated. A negative control reaction (yeast tRNA) showed no evidence of these bands (data not shown). (b) Bands representing induced caspase 8 and DR4 mRNAs were quantitated by normalizing their intensities to L32 band densities. These band intensity ratios are expressed as fold induction for vector-transfected (white bars), and IP6K2-transfected (gray bars) cells with IFN-b and g-irradiation was no greater than that following radiation alone (not shown). It is possible that in NIH-OVCAR-3 cells, caspase 8 activity is already maximized following radiation.
Overexpression of IP6K2 enhanced the degree of apoptosis induced by several dierent stimuli, including chemotherapeutic drugs, IFNs, and g-irradiation.
Expression of the dominant negative SUB mutant interferes with kinase activity (Morrison et al., 2001) and abrogates death induced by all these agents. IP6K2 protein levels are elevated following IFN-b and irradiation (Figure 1 ). These ®ndings suggest that IP6K2 functions as a positive regulator of cell death pathways. The mechanism by which this inositol phosphate kinase promotes apoptosis is unclear. IP6K2 converts IP 6 to InsP 5 PP. It is possible that InsP 5 PP, which contains a pyrophosphate linkage, may function as an energy source that facilitates DISC assembly or signal transduction to the caspase cascade. Proteins that bind IP 6 include the clathrin assembly proteins AP-2, AP-3, and AP-180 (involved in membrane fusion) (Norris et al., 1995; Voglmaier et al., 1992; Ye et al., 1995) , the synaptotagmins (involved in exocytosis of synaptic vesicles) (Mehrotra et al., 2000) and arrestin (which acts as an adapter during endocytosis) (Gaidarov et al., 1999) . All these proteins are closely associated with the plasma membrane. Studies in yeast have suggested that the higher inositol phosphates play a role in mRNA export from the nucleus (Saiardi et al., 2000; York et al., 1999) . Finally, IP 6 was found to speci®cally stimulate repair of double-strand breaks in DNA by the process of nonhomologous end-joining in vitro (Hanakahi et al., 2000) . If the functions of InsP 5 PP and IP 6 prove to be antagonistic, InsP 5 PP may inhibit DNA repair and thereby promote apoptosis.
Materials and methods
Reagents
Mouse anti-IP6K2 monoclonal antibody raised against fulllength bacterially expressed rhIP6K2 (made in our laboratory); Human IFN-b speci®c activity 2.7610 8 U/mg protein (Ares Serono); Rnasin (Promega); GACU, T7 RNA polymerase, T1 RNase (GIBCO BRL); DNase I (Boehringer Mannheim); Multi-Probe Template Set hAPO-3c, (Pharmingen); and monoclonal anti-actin antibodies (Sigma) were employed in these studies.
Cell lines and treatments
NIH-OVCAR-3 (mutant p53) and Caov-3 cells (mutant p53) were obtained from American Type Culture Collection (Rockville, MD, USA). Hey cells (wild-type p53) were obtained from Dr Yan Xu (Cleveland Clinic Foundation). Gamma irradiation was delivered by a 137 Cs source emitting at a ®xed-dose rate of 5 Gy/min.
Plasmids
Three regions of the IP6K2 cDNA were cloned into the pCXN2 vector (Murakami et al., 1995) to create truncation mutants: (A) residues 1 ± 153; (B) residues 154 ± 338; (C) residues 339 ± 419, utilizing a PCR technique described previously (Morrison et al., 2001) . A C-terminal myc tag was added, which allowed detection of expressed IP6K2 proteins by means of anti-myc antibodies (Zymed). A substitution mutant (SUB) was created using PCR based site-directed mutagenesis (Stratagene) with full-length IP6K2 as template, creating point mutations at seven of nine residues within the highly conserved putative inositol phosphate binding domain (IPBD) (Morrison et al., 2001) . PCR products were digested with DpnI, ligated, then transformed into JM109 E. coli, and plasmids isolated. Mutations were con®rmed by sequencing. Similarly, Bcl-2 and DR5D were cloned into pCXN2. DR5D lacks the death domain of DR5, and functions as a dominant negative mutant, interrupting the function of endogenous DR5 (Gong and Almasan, 2000; MacFarlane et al., 1997) . Constructs were transfected into cells using Lipofectamine (Gibco BRL) and stable transfectants were selected and maintained with G418. After 3 weeks selection, surviving clones were pooled for further studies. Expression of IP6K2 mutants was monitored by Western blotting using anti-myc antibodies.
Clonogenic assay
NIH-OVCAR-3 and Hey ovarian carcinoma cells were stably transfected with pCXN2 vector alone or with various IP6K2 constructs, or Bcl-2 or DR5D. Cells were irradiated with a 137 Cs source (Shepherd) at a constant rate of 5 Gy/min for a total dose of 0, 2, or 4 Gy and were plated in 10 cm dishes Figure 6 Caspase 8 activity is increased by g-irradiation and IFN-b. NIH-OVCAR-3 cells expressing pCNX2 (white bars) or IP6K2 (gray bars) were exposed to (a) 2 Gy or (b) 200 U/ml IFN-b and were assayed for caspase 8 activity at 0 ± 72 h. Bars represent caspase 8 activity+s.e.m. of three independent experiments. Enzyme activities were normalized to values obtained with untreated cells (0 h) and expressed as fold induction for each cell type. Column 1 in each graph represents caspase 8 activity in the presence of IETD-fmk (Inhibitor) and incubated at 378C. After 30 days growth, cells were ®xed with 10% TCA (trichloroacetic acid), stained with 0.4% sulforhodamine-B (SRB) in 1% acetic acid, and washed in 1% acetic acid. Colony forming units (CFU) were counted and individual colony area was determined (Kodak 1DS system). A colony was de®ned as a single mass of 50 cells or greater.
Western blot analysis
Total cell protein (80 mg) was separated on 10% SDS ± PAGE and transferred to PVDF membrane. To detect endogenous IP6K2, membranes were incubated with IP6K2 mouse monoclonal antibody. After washing, membranes were incubated with Goat Anti-Mouse IgG (H+L)-HRP conjugate (BIO-RAD) and developed using Western blot Chemiluminescence Reagent Plus (NEN Life Science Products). Myc-tagged IP6K2 constructs were detected with mouse anti-c myc antibodies (Zymed). Blots were stripped and re-probed with anti-actin antibodies (Sigma). IP6K2 band densities were quanti®ed and expressed as a ratio compared to actin.
Ribonuclease protection assay (RPA)
NIH-OVCAR-3 cells were stably transfected with pCXN2 vector alone or with IP6K2. Some cells were pre-treated with actinomycin D (10 mg/ml) for 1 h. NIH-OVCAR-3 and Hey cells received 0, 1 or 2 Gy, as was done in the clonogenic assay. At 0, 1, 2 and 4 h, total RNA was isolated with RNAzol (Teltest). Radiolabeling of the multi-probe template set was performed as described (Gong and Almasan, 2000) according to the manufacturer's recommendation (hAPO-3c, Pharmingen). Total RNA (10 mg) was hybridized with multiprobe for 16 h. After RNase treatment, RNase-protected fragments were resolved on 4.5% denaturing polyacrylamide gels and subject to autoradiography. Band intensities were digitally quanti®ed and expressed as a ratio compared to the ribosomal gene L32.
Cell growth assay
NIH-OVCAR-3 cells transfected with pCXN2 vector alone, or with IP6K2, or Bcl-2, or DR5D were treated with IFN-b during growth in RPMI-1640 (Cellgro) and 5% FBS (HyClone). Growth was monitored using a colorimetric assay that measured cell number (Skehan et al., 1990) . Each treatment group contained eight replicates. Cells were ®xed with TCA and stained with sulphorhodamine B after 7 days. Bound dye was eluted from cells and absorbance (A exp ) was measured at 570 nm. One plate was ®xed 8 h after plating to determine the absorbance representing starting cell number (A ini ). Absorbance with this plate and that obtained with untreated cells at the end of the growth period (A ®n ) were taken as 0 and 100% growth, respectively. Thus, Per cent Control Growth100%ÃA exp À A ini aA fin À A ini 1 Expressed as a per cent of untreated controls, a decrease in cell number (death) is represented as a negative value on the y-axis.
Caspase-8 activity assay
Cells received 0 or 2 Gy, or 200 U/ml IFN-b. At various times, cells were counted and lysed for each caspase 8 assay (Clonetech). The substrate, IETD-AFC, consists of a synthetic peptide (sequence: IETD) conjugated to the chromophore, 7-amino-4-tri¯uoromethyl coumarin (AFC), that is cleaved by activated caspase 8 and is detected uorometrically using a 400 nm excitation ®lter and a 505 nm emission ®lter. Reactions were performed in triplicate.
Abbreviations AFC, 7-amino-4-tri¯uoromethyl coumarin; CFU, colony forming unit; DISC, death-inducing signaling complex; DR, death receptor; DMF, dose modi®cation factor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Gy, gray; IETD, Ile-Glu-Thr-Asp; IFN, interferon; IP6K2, inositol hexakisphosphate kinase 2; RPA, ribonuclease protection assay; SRB, sulforhodamine B; TRAIL, TNFrelated apoptosis-inducing ligand
